HPV Testing and Pap Test Market worth 4,523.1 Million USD by 2020

(IT-NEWSWIRE.COM, July 31, 2017 ) The report "HPV Testing & Pap Test Market by Test Type (HPV Testing (Follow-Up, Co-Testing, Primary)), by Application (Pap Test (Cervical Cancer, Vaginal Cancer)), by End User (Laboratories, Hospitals, Physicians’ Offices & Clinics) - Global Forecast to 2020", provides a detailed overview of the major drivers, restraints, opportunities, challenges, current market trends, and strategies impacting the market along with estimates and forecasts of revenue.

Browse 80 market data Tables and 52 Figures spread through 124 Pages and in-depth TOC on "HPV Testing & Pap Test Market by Test Type (HPV Testing (Follow-Up, Co-Testing, Primary)), by Application (Pap Test (Cervical Cancer, Vaginal Cancer)), by End User (Laboratories, Hospitals, Physicians’ Offices & Clinics) - Global Forecast to 2020"

Early buyers will receive 10% customization on reports.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=214207371

A number of factors such as increasing number of cervical cancer cases, growing aging population, increasing awareness of cervical cancer screening programs, and government initiative and funding are propelling the growth of the HPV testing and Pap test market. However, changes in regulatory guidelines for cervical cancer screening and HPV vaccination are some major factors restraining the growth of this market. In addition to this, the uncertain reimbursement scenario serves to be a major challenge impacting the growth of the HPV test and Pap test market.

HPV testing and Pap test market has been divided into two major segments on basis of test type, namely, HPV testing and Pap test. Follow-up HPV testing, co-testing, HPV primary testing are three sub-segments of HPV testing. The Pap test segment is expected to account for the largest share of the HPV testing and Pap test market in 2015. HPV testing segment is expected to grow at the highest CAGR in the next five years. This fastest growth is attributed to the increasing incidences of cervical cancer, raising awareness of HPV screening, as well as the introduction of HPV primary test.

Download Free Report Sample Pages: http://www.marketsandmarkets.com/requestsample.asp?id=214207371

On the basis of type of application, the global HPV testing and Pap test market is classified into two major segments, namely, cervical cancer screening and vaginal cancer screening. The cervical cancer screening application segment is expected account for the largest share of the Pap test market in 2015. This large share can be attributed to the increasing incidences of cervical cancer and government initiatives to spread the awareness about cervical cancer screening.

HPV testing and Pap test market is classified into three segments on the basis of end users, namely, hospitals, laboratories, physicians’ offices and clinics. The laboratories end-user segment is expected account for the largest share of the HPV testing and Pap test market in 2015. Furthermore, the hospitals end-user segment is expected to grow at the highest CAGR in the next five years, as most of the diagnostic tests are carried out in-house in hospitals with advanced technologies in shorter period of time.

Abbott Laboratories (U.S.), Qiagen N.V. (The Netherlands), Hologic Inc. (U.S.), Roche Diagnostics (Switzerland), Quest Diagnostics (U.S.), Becton, Dickinson and Company (U.S.) are the key players operating in the HPV testing and Pap test market.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street,
Suite 2175, Seattle,
WA 98101, United States
1-888-600-6441
Email: sales@marketsandmarkets.com

MarketsandMarkets

Mr. Rohan

1-888-600-6441

sales@marketsandmarkets.com

Source: EmailWire.Com

Source: EmailWire.com

Technology News & Search Engine

HPV Testing and Pap Test Market worth 4,523.1 Million USD by 2020